secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sigyn Therapeutics, Inc. (SIGY)
CIK:        0001642159
Form:       8-K
Filed at:   2025-01-06T23:59:59+00:00
Accession:  0001493152-25-001074
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sigyn Therapeutics reduces authorized common shares to 100M via charter amendment
--------------------------------------------------------------------------------

- Filed Certificate of Amendment decreasing authorized common stock to 100 million shares (par value $0.0001).
- Authorized preferred stock unchanged at 10 million shares (par value $0.0001).
- Amendment effective upon filing on December 30, 2024.
- No other changes to the Amended and Restated Certificate of Incorporation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642159/000149315225001074/0001493152-25-001074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642159/000149315225001074/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-001074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer